Publications by authors named "P Cervantes"

Claim this Profile
P
Pathway-Specific Polygenic Scores for Predicting Clinical Lithium Treatment Response in Patients With Bipolar Disorder.
Nigussie T Sharew, Scott R Clark, Sergi Papiol, Urs Heilbronner, Franziska Degenhardt, Pablo Cervantes

Biol Psychiatry Glob Open Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Novel and prevalent non-East Asian ALDH2 variants; implications for global susceptibility to aldehydes' toxicity EBioMedicine (2020) - doi: 10.1016/j.ebiom.2020.102753.
Che-Hong Chen, Julio C B Ferreira, Amit U Joshi, Matthew C Stevens, Sin-Jin Li, Pilar R Cervantes

EBioMedicine· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune, Developmental, and Synaptic Pathways Define Bipolar Disorder Clinical Heterogeneity.
Tracey van der Veen, Markos Tesfaye, Jessica Mei Kay Yang, Toni Boltz, Friederike S David, Pablo Cervantes

medRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study.
Philippe L Bedard, Komal L Jhaveri, Melissa K Accordino, Prof Andrés Cervantes, Valentina Gambardella

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis